3-benzoyl dopamine has been researched along with Chronic Illness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fautrel, B; Hajage, D; Kossi, S; Marotte, H; Moysidou, GS; Tubach, F | 1 |
1 trial(s) available for 3-benzoyl dopamine and Chronic Illness
| Article | Year |
|---|---|
Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Chronic Disease; Humans; Recurrence; Severity of Illness Index; Tumor Necrosis Factor Inhibitors | 2023 |